A detailed history of Legacy Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Legacy Advisors, LLC holds 8,995 shares of AMGN stock, worth $2.8 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
8,995
Previous 11,155 19.36%
Holding current value
$2.8 Million
Previous $3.21 Million 20.39%
% of portfolio
0.32%
Previous 0.41%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$268.87 - $324.56 $580,759 - $701,049
-2,160 Reduced 19.36%
8,995 $2.56 Million
Q4 2023

Feb 12, 2024

SELL
$255.7 - $288.46 $772,469 - $871,437
-3,021 Reduced 21.31%
11,155 $3.21 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $47,447 - $58,906
-217 Reduced 1.51%
14,176 $3.81 Million
Q2 2023

Jul 20, 2023

SELL
$214.27 - $253.37 $63,209 - $74,744
-295 Reduced 2.01%
14,393 $3.2 Million
Q1 2023

May 01, 2023

BUY
$225.79 - $275.2 $167,536 - $204,198
742 Added 5.32%
14,688 $3.55 Million
Q4 2022

Feb 01, 2023

SELL
$229.03 - $291.01 $31,606 - $40,159
-138 Reduced 0.98%
13,946 $3.66 Million
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $94,722 - $106,829
422 Added 3.09%
14,084 $3.18 Million
Q2 2022

Jul 25, 2022

BUY
$230.71 - $256.74 $492,796 - $548,396
2,136 Added 18.53%
13,662 $3.32 Million
Q1 2022

May 11, 2022

BUY
$219.27 - $242.57 $1.9 Million - $2.1 Million
8,675 Added 304.28%
11,526 $2.79 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $25,854 - $29,588
-130 Reduced 4.36%
2,851 $641,000
Q3 2021

Oct 13, 2021

BUY
$212.27 - $248.7 $5,094 - $5,968
24 Added 0.81%
2,981 $634,000
Q2 2021

Jul 13, 2021

BUY
$233.58 - $259.14 $4,204 - $4,664
18 Added 0.61%
2,957 $721,000
Q1 2021

Apr 12, 2021

SELL
$221.91 - $258.6 $61,247 - $71,373
-276 Reduced 8.58%
2,939 $731,000
Q4 2020

Jan 15, 2021

BUY
$216.38 - $257.67 $3,678 - $4,380
17 Added 0.53%
3,215 $739,000
Q3 2020

Oct 08, 2020

BUY
$234.65 - $260.95 $3,754 - $4,175
16 Added 0.5%
3,198 $813,000
Q2 2020

Jul 09, 2020

BUY
$197.81 - $242.74 $1,582 - $1,941
8 Added 0.25%
3,182 $750,000
Q1 2020

Apr 15, 2020

SELL
$182.24 - $241.7 $45,742 - $60,666
-251 Reduced 7.33%
3,174 $643,000
Q4 2019

Jan 21, 2020

BUY
$189.21 - $243.2 $50,329 - $64,691
266 Added 8.42%
3,425 $826,000
Q3 2019

Oct 10, 2019

BUY
$174.11 - $208.62 $3,133 - $3,755
18 Added 0.57%
3,159 $611,000
Q2 2019

Jul 15, 2019

SELL
$166.7 - $195.41 $79,349 - $93,015
-476 Reduced 13.16%
3,141 $579,000
Q1 2019

Apr 08, 2019

SELL
$180.87 - $203.88 $105,266 - $118,658
-582 Reduced 13.86%
3,617 $687,000
Q4 2018

Jan 14, 2019

SELL
$178.4 - $208.25 $1.26 Million - $1.47 Million
-7,054 Reduced 62.69%
4,199 $817,000
Q3 2018

Oct 18, 2018

BUY
$185.29 - $208.89 $1.6 Million - $1.81 Million
8,655 Added 333.14%
11,253 $2.33 Million
Q2 2018

Jul 19, 2018

BUY
$166.05 - $186.51 $32,877 - $36,928
198 Added 8.25%
2,598 $480,000
Q1 2018

Apr 17, 2018

BUY
$169.43 - $198.0 $397,821 - $464,904
2,348 Added 4515.38%
2,400 $411,000
Q3 2017

Nov 03, 2017

BUY
$167.29 - $191.0 $8,699 - $9,932
52 New
52 $9,000
Q1 2017

Nov 02, 2017

SELL
N/A
-257 Closed
0 $0
Q4 2016

Nov 03, 2017

BUY
N/A
257
257 $37,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Legacy Advisors, LLC Portfolio

Follow Legacy Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Advisors, LLC with notifications on news.